Cardiovascular Diseases Clinical Trial
To develop a scientifically valid and ethnically approved, lay-led smoking cessation intervention for Southeast Asian men and women, i-e., those from Cambodia, Laos, and Vietnam.
BACKGROUND:
Economically disadvantaged Southeast Asian men were targeted because of their higher than
average smoking prevalence rate, their extraordinary increased numbers, and the relative
paucity of strategies to reach this hard-to-reach group.
DESIGN NARRATIVE:
Trained, lay S.E. Asian counselors (cadre) were the primary agents for this study's
assessment, intervention, and follow -up of smoking cessation behaviors. Seven reasons for
using this approach were cited, including the potential generalization of this approach to
other populations.
Over the six year demonstration and education research study period, the investigators:
collected baseline data on smoking and smoking cessation behaviors; designed ethnically
approved strategies for the cessation and maintenance of smoking cessation behaviors based
upon findings from the baseline assessment; implemented ethnically approved strategies for
smoking cessation; maintained smoking cessation after initial quitting; and evaluated the
effectiveness of the intervention.
On the macro level, an equal number of randomly selected subjects (E1) allocated equally
among the three ethnic groups in one county were compared to an equal number of control
subjects in geographically separate counties. On the micro level, E1 subjects were also
compared to control subjects (C1) in the intervention county. All subjects were
longitudinally followed. The standard for successful cessation was biochemically verified
through salivary cotinine tests at one year of self-reported abstinence.
Among the study's features were the community-based (versus academic or clinical) nature of
lay change agents, the deliberate integration of baseline data and scientific principles
with ethnic values in the intervention approach, and a research design that allowed for both
macro and micro comparisons of the intervention with control conditions.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|